UMB Bank’s Amedisys AMED Stock Holding History

UMB Bank’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-432	Closed	-$42.5K	–	2153
2025 Q2	$42.5K	Buy	432 +46	+12%	+$4.35K	﹤0.01%	1169
2025 Q1	$35.8K	Buy	386 +193	+100%	+$17.8K	﹤0.01%	1180
2024 Q4	$17.5K	Buy	193 +174	+916%	+$16K	﹤0.01%	1307
2024 Q3	$1.83K	Hold	19	–	–	﹤0.01%	2001
2024 Q2	$1.74K	Buy	19 +9	+90%	+$835	﹤0.01%	1829
2024 Q1	$922	Buy	+10	New	+$937	﹤0.01%	1808
2023 Q3	–	Sell	-10	Closed	-$914	–	1693
2023 Q2	$914	Hold	10	–	–	﹤0.01%	1600
2023 Q1	$736	Hold	10	–	–	﹤0.01%	1626
2022 Q4	$1K	Hold	10	–	–	﹤0.01%	1585
2022 Q3	$1K	Sell	10 -88	-90%	-$10.5K	﹤0.01%	1640
2022 Q2	$10K	Sell	98 -44	-31%	-$5.62K	﹤0.01%	1380
2022 Q1	$24K	Hold	142	–	–	﹤0.01%	1184
2021 Q4	$23K	Buy	+142	New	+$22.8K	﹤0.01%	1228

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

UMB Bank's AMED Position: Q3 2025 in Review

UMB Bank sold out of Amedisys (AMED) in Q3 2025, closing a stake of 432 shares — an estimated $42.5K sold.

UMB Bank first reported a position in AMED in Q4 2021 and held it in 13 quarters. The position peaked at $42.5K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

UMB Bank reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
UMB Bank sold 432 Amedisys shares in Q3 2025, an estimated $42.5K.
UMB Bank first reported a position in Amedisys in Q4 2021 and held it in 13 quarters.
UMB Bank's Amedisys position peaked at $42.5K in Q2 2025.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on UMB Bank's 13F filing for Q3 2025, filed 4 Nov 2025.